Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2017

Sep 26, 2017

29777_dirs_2017-09-26_95a84bd1-b381-4b43-be2a-dac1a7ef54ad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-09-22

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-22 Common shares without par value M 13400 $26.1879 Acquired 58739 Direct
2017-09-22 Common shares without par value M 17300 $22.3919 Acquired 76039 Direct
2017-09-22 Common shares without par value M 22000 $27.0336 Acquired 98039 Direct
2017-09-22 Common shares without par value S 34400 $51.95 Disposed 63639 Direct
2017-09-22 Common shares without par value S 4152 $51.96 Disposed 59487 Direct
2017-09-22 Common shares without par value S 1701 $51.97 Disposed 57786 Direct
2017-09-22 Common shares without par value S 1913 $51.98 Disposed 55873 Direct
2017-09-22 Common shares without par value S 909 $51.99 Disposed 54964 Direct
2017-09-22 Common shares without par value S 1109 $52 Disposed 53855 Direct
2017-09-22 Common shares without par value S 3816 $52.01 Disposed 50039 Direct
2017-09-22 Common shares without par value S 1600 $52.02 Disposed 48439 Direct
2017-09-22 Common shares without par value S 200 $52.025 Disposed 48239 Direct
2017-09-22 Common shares without par value S 500 $52.03 Disposed 47739 Direct
2017-09-22 Common shares without par value S 1200 $52.04 Disposed 46539 Direct
2017-09-22 Common shares without par value S 1200 $52.041 Disposed 45339 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-22 Option (right to buy) $26.1879 M 13400 Disposed 2020-02-18 Common shares (13400) Direct
2017-09-22 Option (right to buy) $22.3919 M 17300 Disposed 2021-02-17 Common shares (17300) Direct
2017-09-22 Option (right to buy) $27.0336 M 22000 Disposed 2022-02-16 Common shares (22000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 21 Indirect
Common shares without par value 64297 Indirect
Common shares without par value 2410 Indirect
Common shares without par value 12081 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 22, 2017.

F2: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F3: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F4: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

F5: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.